Kaitlin A Quinn1,2, Peter C Grayson1. 1. Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA. 2. Division of Rheumatology, Georgetown University, Washington DC, USA.
Abstract
PURPOSE OF THE REVIEW: The two main forms of large-vessel vasculitis (LVV) are giant cell arteritis (GCA) and Takayasu's arteritis (TAK). Vascular imaging can characterize disease activity and disease extent in LVV. This review critically analyzes the clinical utility of vascular imaging in LVV and highlights how imaging may be incorporated into the management and study of these conditions. RECENT FINDINGS: There are multiple imaging modalities available to assess LVV including ultrasonography, CT angiography (CTA), magnetic resonance angiography (MRA), and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). As these techniques are refined, imaging may be increasingly useful to evaluate the cranial arteries and the aorta and its primary branches. In addition, vascular imaging may be useful to monitor disease activity and may have prognostic value to predict future clinical events. SUMMARY: There are strengths and weaknesses associated with vascular imaging that should be considered when evaluating patients with LVV. Vascular imaging will likely play an increasingly important role in the clinical management of patients and the conduct of research in LVV and may ultimately be incorporated as outcome measures in clinical trials in these conditions.
PURPOSE OF THE REVIEW: The two main forms of large-vessel vasculitis (LVV) are giant cell arteritis (GCA) and Takayasu's arteritis (TAK). Vascular imaging can characterize disease activity and disease extent in LVV. This review critically analyzes the clinical utility of vascular imaging in LVV and highlights how imaging may be incorporated into the management and study of these conditions. RECENT FINDINGS: There are multiple imaging modalities available to assess LVV including ultrasonography, CT angiography (CTA), magnetic resonance angiography (MRA), and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). As these techniques are refined, imaging may be increasingly useful to evaluate the cranial arteries and the aorta and its primary branches. In addition, vascular imaging may be useful to monitor disease activity and may have prognostic value to predict future clinical events. SUMMARY: There are strengths and weaknesses associated with vascular imaging that should be considered when evaluating patients with LVV. Vascular imaging will likely play an increasingly important role in the clinical management of patients and the conduct of research in LVV and may ultimately be incorporated as outcome measures in clinical trials in these conditions.
Authors: Arend F L Schinkel; Stijn C H van den Oord; Antonius F W van der Steen; Jan A M van Laar; Eric J G Sijbrands Journal: Eur Heart J Cardiovasc Imaging Date: 2013-11-17 Impact factor: 6.875
Authors: Giuseppe Germanò; Pierluigi Macchioni; Niccolò Possemato; Luigi Boiardi; Alberto Nicolini; Massimiliano Casali; Annibale Versari; Nicolò Pipitone; Carlo Salvarani Journal: Arthritis Care Res (Hoboken) Date: 2016-11-16 Impact factor: 4.794
Authors: Peter C Grayson; Gunnar Tomasson; David Cuthbertson; Simon Carette; Gary S Hoffman; Nader A Khalidi; Carol A Langford; Carol A McAlear; Paul A Monach; Philip Seo; Kenneth J Warrington; Steven R Ytterberg; Peter A Merkel Journal: J Rheumatol Date: 2011-12-15 Impact factor: 4.666
Authors: William Febry Jiemy; Peter Heeringa; Jan A A M Kamps; Conny J van der Laken; Riemer H J A Slart; Elisabeth Brouwer Journal: Autoimmun Rev Date: 2018-05-03 Impact factor: 9.754
Authors: Charles Oshinsky; Alison M Bays; Ingeborg Sacksen; Elizabeth Jernberg; R Eugene Zierler; Andreas P Diamantopoulos; Jean W Liew; Sarah H Chung; P Scott Pollock Journal: ACR Open Rheumatol Date: 2021-10-14
Authors: Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba Journal: Eur J Nucl Med Mol Imaging Date: 2020-10-27 Impact factor: 9.236